Osteopenia Terminated Phase 3 Trials for Alendronic acid (DB00630)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000430Low-Dose Hormone Replacement Therapy and Alendronate for OsteoporosisTreatment